Quality Control of Ventral Hernia Surgery by Prospective Registration
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Nov 9, 2020
Trial Information
Current as of November 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the quality of surgery for ventral hernias, which are bulges that can occur in the abdominal wall. The study will take place in 21 hospitals in Belgium and will work closely with the Danish Hernia Database to gather important information about hernia surgeries. By tracking and analyzing this data, the researchers hope to enhance the safety and effectiveness of these procedures.
To be eligible for the trial, participants must be at least 18 years old and have either elective (planned) or emergency surgery for a ventral or incisional hernia. They also need to be treated by a surgeon who is part of this study. Unfortunately, if someone is younger than 18, pregnant, or not treated by a participating surgeon, they won't be able to join. Participants can expect to provide informed consent, meaning they understand and agree to take part in the study. This trial aims to make hernia surgeries safer and more successful for everyone involved.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Consecutively all patients with an elective or emergency repair of every ventral/incisional hernia (including parastomal hernia)
- • Male and female
- • 18 years or older
- • Operated of supervised by a participating surgeon (participating in this study is not necessarily by a whole surgical department of one of the 18 participating Belgian hospitals, but by specific surgeons)
- • Elective and emergency surgery
- • Signed informed consent form
- • Exclusion criteria
- • Younger than 18 years
- • Not operated or supervised by participating surgeon
- • Pregnant at inclusion in the registry
- • No signed informed consent form
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials